Radboudumc is exploring the market for functionally equivalent solutions for DNA extraction and real-time PCR within the molecular diagnostics of medical microbiology. The current workflow includes pipetting robots, extraction equipment, and qPCR instruments, connected via middleware and LIS. The goal is to replace 2 nucleic acid extraction platforms (96-wells) and 4 qPCR analyzers, while maintaining integration within the current molecular diagnostic platform and throughput time. The systems must have a proven track record of at least 5 years in medical microbiological molecular diagnostics in an ISO 15189 accredited laboratory or equivalent accreditation. This also applies to the integration with existing middleware and LIS (AuroraFlow ↔ GLIMS/HL7).

PAR-0000
Market Consultation Molecular Diagnostics – Extraction and qPCR.
Radboudumc is exploring the market for functionally equivalent solutions for DNA extraction and real-time PCR within the molecular diagnostics of medical microbiology. The current workflow includes pipetting robots, extraction equipment, and qPCR instruments, connected via middleware and LIS. The goal is to replace 2 nucleic acid extraction platforms (96-wells) and 4 qPCR analyzers, while maintaining integration within the current molecular diagnostic platform and throughput time. The systems must have a proven track record of at least 5 years in medical microbiological molecular diagnostics in an ISO 15189 accredited laboratory or equivalent accreditation. This also applies to the integration with existing middleware and LIS (AuroraFlow ↔ GLIMS/HL7).